The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1975, 115: 1060-1064.
Copyright © 1975 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dean, J. H.
Right arrow Articles by Herberman, R. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dean, J. H.
Right arrow Articles by Herberman, R. B.

In Vitro Human Reactivity to Staphylococcal Phage Lysate1

J. H. Dean, J. S. Silva, J. L. McCoy, S. P. Chan, J. J. Baker, C. Leonard and R. B. Herberman

From the Department of Immunology, Litton Bionetics, Inc., Kensington, Md. 20795, and the Medical Center, Keesler Air Force Base, Biloxi, Miss. 39531, and the Laboratory of Immunodiagnosis, National Cancer Institute, Bethesda, Md. 20014

Abstract

The cell-mediated reactivity of normal individuals to staphylococcal phage lysate (SPL) were tested in vitro in the lymphocyte stimulation (LS) and leukocyte migration inhibition (LMI) assays. There were 95% positive responses in LS (stimulation ratio ≥ 3 with p < 0.01) and 67% positive responses in LMI (migration index ≤ 0.80). Enriched subpopulations of T and B lymphocytes were prepared with rosette formation and density gradient centrifugation. SPL stimulated lymphoproliferative responses in both T and B cell subpopulations whereas phytohemagglutinin (PHA) stimulated only the T cell subpopulation. Cord blood leukocytes were tested in the LS assay and 41% gave positive responses to SPL, 81% to PHA, and 17% with SLO. SPL appears to be a useful reagent for the in vitro study of cell-mediated reactivity, and may provide somewhat different information from that obtained with other mitogens or antigens.

Footnotes

1 This work was supported in part by United States Public Health Service Contracts NIH-NCI-72-3227 and NIH-NIDR-7-72-14R from the National Institutes of Health, Bethesda, Md. 20014.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.